GlassScriptPhysician profile
David M Salvay
NPI 1700173655
$6,585.25
in general payments reported to CMS, 2019-2025
30 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,895 · 2020: $114 · 2021: $446 · 2022: $1,139 · 2023: $976 · 2024: $564 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,990.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,584.72 | 2019-2024 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Alcon Vision LLC | $835.58 | 2021-2025 | Tryptyr, Rocklatan, Argos |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $514.82 | 2019-2020 | |
| Rxsight INC | $475.87 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Glaukos Corporation | $452.17 | 2019-2025 | Photrexa Cross-Linking Kit, Idosetr, Idose |
| Amgen INC. | $428.38 | 2025 | Tepezza |
| Abbvie INC. | $333.03 | 2022-2025 | Xen Glaucoma Treatment System |
| Tarsus Pharmaceuticals, INC. | $296.29 | 2024-2025 | Xdemvy |
| Lumenis Be INC | $252.05 | 2023 | Optilight |
| Carl Zeiss Meditec, INC. | $208.77 | 2019-2021 | |
| New World Medical,INC. | $201.12 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $155.92 | 2022 | |
| Harrow Eye, LLC | $131.79 | 2024-2025 | Vevye, Iheezo |
| Eyepoint US, INC. | $124.10 | 2021 | |
| Beaver-Visitec International, INC. | $76.11 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $75.80 | 2024 | Lensar Laser System |
| Astellas Pharma US INC | $64.18 | 2024 | Izervay |
| Sun Pharmaceutical Industries INC. | $49.02 | 2020-2025 | |
| Bausch & Lomb Americas INC. | $46.39 | 2025 | Scoutpro Osmolarity System |
| Akorn, INC. | $36.34 | 2020 | |
| Sight Sciences, INC. | $34.89 | 2021-2023 | Tearcare System |
| Oyster Point Pharma, INC. | $34.35 | 2024 | Ryzumvi, Tyrvaya |
| Mallinckrodt Hospital Products INC. | $34.08 | 2022 | |
| Topcon Healthcare, INC. | $24.45 | 2025 | |
| Kala Pharmaceuticals, INC. | $22.42 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Thea Pharma INC. | $19.35 | 2024 | Iyuzeh |
| Optos, INC. | $18.87 | 2021 | |
| Eyevance Pharmaceuticals LLC | $17.56 | 2020 | |
| Ocular Therapeutix, INC. | $17.43 | 2023 | Dextenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Salvay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.